Preview Mode Links will not work in preview mode

Evidence and experts to help you understand today’s public health news—and what it means for tomorrow.

Apr 20, 2022

The Biden administration recently approved nearly $10 billion to broaden access to PrEP, a medication that is 99% effective at preventing HIV and key to ending the nation’s HIV epidemic. Amy Killelea, a policy expert on HIV and public health financing, talks with Stephanie Desmon about why health policies have meant this game-changing drug hasn’t yet delivered on its potential, how experts hope Biden’s budget will build a better nationwide PrEP distribution system, and how much is at stake at this particular turning point in the epidemic.